Does GOLIMUMAB Cause Neoplasm malignant? 556 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 556 reports of Neoplasm malignant have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 0.8% of all adverse event reports for GOLIMUMAB.
556
Reports of Neoplasm malignant with GOLIMUMAB
0.8%
of all GOLIMUMAB reports
68
Deaths
149
Hospitalizations
How Dangerous Is Neoplasm malignant From GOLIMUMAB?
Of the 556 reports, 68 (12.2%) resulted in death, 149 (26.8%) required hospitalization, and 26 (4.7%) were considered life-threatening.
Is Neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 556 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Neoplasm malignant?
RANITIDINE (10,648)
ADALIMUMAB (2,028)
APIXABAN (1,772)
ETANERCEPT (1,616)
METHOTREXATE (1,041)
TOFACITINIB (1,020)
RITUXIMAB (929)
INFLIXIMAB (892)
ABATACEPT (727)
RISANKIZUMAB-RZAA (715)
Which GOLIMUMAB Alternatives Have Lower Neoplasm malignant Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN